ELOXX PHARMACEUTICALS, INC. Net Fee Amt
ELOXX PHARMACEUTICALS, INC. (ELOX) had Net Fee Amt of $11.23 thousand as of 2026-09-11, per its S-1 filed 2026-09-11.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-09-11
- 2026-09-11: Net Fee Amt $11.23K.
- 2026-06-04: Net Fee Amt $759.55.
- 2026-06-01: Net Fee Amt $1.45K.
- 2026-05-07: Net Fee Amt $6.91K.
| Period end | Net Fee Amt |
|---|---|
| 2026-09-11 | $11.23K S-1 · filed 2026-09-11 |
| 2026-06-04 | $759.55 S-1/A · filed 2026-06-04 |
| 2026-06-01 | $1.45K S-1/A · filed 2026-06-01 |
| 2026-05-07 | $6.91K S-1 · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |